Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas - a single centre experience.

作者: Lucka Boltezar , Karlo Pintaric , Jože Pretnar , Maja Pohar Perme , Barbara Jezersek Novakovic

DOI: 10.1515/RAON-2016-0040

关键词:

摘要: Background: Advanced follicular lymphoma (FL) and mantle cell (MCL) are incurable diseases with conventional treatment. The high dose treatment (HDT) autologous stem transplantation (ASCT), however, offers a certain proportion of these patients the prospect prolonged disease-free overall survival. aim this study was to investigate event free survival (EFS) (OS) in FL MCL treated ASCT. Materials methods: Seventeen 29 were included, 15 them transplanted consolidate response second line 24 their first remission, respectively. All conditioned total body irradiation cyclophosphamide between 2006 2014 all peripheral blood cells. Results: estimated 5-year OS for 87.8% (95% CI 59.5% - 96.8) 79.3% 56.1% 91.1%), EFS 76.0% 48.0% 90.3%) 69.8% 45.5% 84.8%), There no secondary hematological malignancies observed either group. Conclusion: ASCT is good option long term bringing about low rate late toxicities malignancies.

参考文章(35)
Francesco Merli, Stefano Luminari, Fiorella Ilariucci, Mario Petrini, Carlo Visco, Achille Ambrosetti, Caterina Stelitano, Francesco Caracciolo, Nicola Di Renzo, Francesco Angrilli, Angelo M Carella, Isabella Capodanno, Elisa Barbolini, Sara Galimberti, Massimo Federico, None, Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi. British Journal of Haematology. ,vol. 156, pp. 346- 353 ,(2012) , 10.1111/J.1365-2141.2011.08958.X
Riikka Oinonen, Esa Jantunen, Maija Itälä, Tuula Lehtinen, Outi Kuittinen, Kaarle Franssila, Tom Wiklund, Erkki Elonen, Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma Leukemia & Lymphoma. ,vol. 43, pp. 1229- 1237 ,(2002) , 10.1080/10428190290026286
Markus Schaaf, Marcel Reiser, Peter Borchmann, Andreas Engert, Nicole Skoetz, High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults Cochrane Database of Systematic Reviews. ,vol. 1, ,(2012) , 10.1002/14651858.CD007678.PUB2
Mojtaba Akhtari, Vijaya Raj Bhatt, Pavan Kumar Tandra, Jairam Krishnamurthy, Heidi Horstman, Amy Dreessen, Pei Xian Chen, James O Armitage, Therapy-related Myeloid Neoplasms After Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Patients Cancer Biology & Therapy. ,vol. 14, pp. 1077- 1088 ,(2013) , 10.4161/CBT.26342
Wendy Ingram, Stephen Devereux, Emma P Das‐Gupta, Nigel H Russell, Andrew P Haynes, Jennifer L Byrne, Bronwen E Shaw, Andrew McMillan, Juan Gonzalez, Aloysius Ho, Ghulam J Mufti, Antonio Pagliuca, None, Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma British Journal of Haematology. ,vol. 141, pp. 235- 243 ,(2008) , 10.1111/J.1365-2141.2008.07067.X
M Attal, P Biron, S Maury, A Rambaldi, J Maertens, S Capria, P Colombat, S Montoto, A Sureda, S P Robinson, C Canals, J J Luang, H Tilly, C Crawley, J Y Cahn, D Pohlreich, S Le Gouill, M Gilleece, N Milpied, The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplantation. ,vol. 48, pp. 1409- 1414 ,(2013) , 10.1038/BMT.2013.83
Marcie R. Tomblyn, Marian Ewell, Christopher Bredeson, Brad S. Kahl, Stacey A. Goodman, Mary M. Horowitz, Julie M. Vose, Robert S. Negrin, Ginna G. Laport, Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular Non-Hodgkin lymphoma beyond first complete response or first partial response Biology of Blood and Marrow Transplantation. ,vol. 17, pp. 1051- 1057 ,(2011) , 10.1016/J.BBMT.2010.11.004
Catherine Sebban, Nicolas Mounier, Nicole Brousse, Coralie Belanger, Pauline Brice, Corinne Haioun, Herve Tilly, Pierre Feugier, Redah Bouabdallah, Chantal Doyen, Gilles Salles, Bertrand Coiffier, Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Blood. ,vol. 108, pp. 2540- 2544 ,(2006) , 10.1182/BLOOD-2006-03-013193
Thomas E. Witzig, Current Treatment Approaches for Mantle-Cell Lymphoma Journal of Clinical Oncology. ,vol. 23, pp. 6409- 6414 ,(2005) , 10.1200/JCO.2005.55.017
I. El-Najjar, A. Boumendil, J.J. Luan, R. Bouabdallah, K. Thomson, M. Mohty, P. Colombat, P. Biron, H. Tilly, M. Pfreundschuh, C. Cordonnier, A. Sureda, J.Y. Cahn, J.P. Vernant, J. Gribben, G. Cook, A.P. Haynes, A. Ferrant, H. Finel, S. Montoto, P. Dreger, The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party Annals of Oncology. ,vol. 25, pp. 2224- 2229 ,(2014) , 10.1093/ANNONC/MDU440